The NIHR is pleased to launch a seventh Research and Innovation for Global Health Transformation (RIGHT) call that will support targeted research to develop and evaluate interventions for the early detection and management of metabolic risk factors for cardiovascular disease and stroke in primary and community care settings.
The NIHR Global Health Research portfolio was established to support applied health research for the direct and primary benefit of people in low and middle-income countries (LMICs) on the Development Assistance Committee (DAC) list, using Official Development Assistance (ODA) from the UK government.
The Global Health Research portfolio is underpinned by three principles which guide development and delivery. These are:
- Meet eligibility criteria as Official Development Assistance (ODA), i.e. funded research directly and primarily benefits people in ODA-eligible countries on the DAC-list
- Deliver high-quality applied health research, building on the Principles of the National Institute of Health and Care Research (NIHR): Impact, Excellence, Effectiveness, Inclusion, and Collaboration
- Strengthen research capability and training through equitable partnerships
The NIHR has established a substantial portfolio of applied global health research and training in areas that are underfunded or where there is an unmet need. The portfolio aims are delivered through a combination of researcher-led and commissioned calls, funding initiatives to develop and advance global health research career pathways both in LMICs and in the UK, and through partnerships with other major global health research funders. Together these have positioned the NIHR as a key player in supporting high-quality applied global health research.
The NIHR is seeking applications to RIGHT Call 7 for programmes of applied health research that focus on the development and evaluation of interventions for the early detection and management of metabolic risk factors for cardiovascular disease and stroke in primary and community care settings.
This funding opportunity is open to lead applicants from UK or LMIC institutions. Please refer to the Guidance for Applicants for further details about applicant eligibility and other documents in the Supporting Information sidebar for full details about this funding call.
RIGHT typically awards funding of £1-5 million (maximum of £5 million) for research projects with a duration of 3-5 years.
Applicants should submit their RIGHT Call 7 Stage 1 application via the Research Management System (RMS). The call will close at 13:00 UK time on Wednesday, 11 October 2023.
Please note all new users need to be validated to access applications which takes up to 48 hours upon registration. The deadline for RMS registrations is 27 September 2023.
NIHR will not accept the same or substantially similar applications across multiple NIHR Global Health Research calls. NIHR will accept applications from the same or similar teams across more than one NIHR Global Health Research call where the aims and research proposals are substantially different.
Read more in our guidance on multiple applications to Global Health Research programmes.
Proposal and Partnership Development Awards
Applicants can apply for a Proposal and Partnership Development Award (PPDA) in conjunction with their RIGHT 7 Stage 1 application.
PPDAs were established to support partnership development and the preparation of a RIGHT Stage 2 application providing funding of up to £10,000. Applicants that are successful at RIGHT Stage 1 and invited to submit a RIGHT Stage 2 application are eligible to receive a PPDA.
Please refer to the PPDA Call 7 Remit and Guidance for Applicants for more information.
- PPDA 7 opened on 05 July 2023 and will close at 13:00 UK time on Wednesday 11 October 2023.
An applicant webinar took place on Wednesday 2 August 2023 at 10am-12pm and 2pm-4pm. A recording of the webinar is now available on the NIHR YouTube channel. A copy of the slides are available and can be requested by contacting the Global Health team at email@example.com.